Drugs
Collagen Corp. has made a significant announcement in its effort to expand its marketing franchise in cosmetic medicine. The company has acquired LipoMatrix Inc., the developer and manufacturer of the Trilucent breast implant, and will be taking a non-recurring charge for in-process research and development. This charge, valued at approximately
Pharmaceutical industry
Genentech, a leading biotechnology company, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Nutropin, human growth hormone, to treat growth failure associated with Turner syndrome. This decision comes after a 12-year research effort and two long-term, multi-center clinical studies sponsored by
Pharmaceutical industry
Sens. Connie Mack and Bill Frist have introduced a bill that would allow drug companies to disseminate information about the off-label uses of their medications to physicians. The information would have to come from a source that was not sponsored by the pharmaceutical company and would disclose that the FDA
Drugs
Top AIDS researchers have concluded that the standard treatment for AIDS patients should be changed from the single-drug therapy AZT to a combination of medications. Two new studies, the European-Australian Delta study and the U.S. AIDS Clinical Trials Group (ACTG) 175 report, have shown that a combination of drugs
Drugs
Researchers at an international AIDS meeting are exploring the use of snake and scorpion venom as novel medications to combat the global AIDS epidemic. The studies, while promising, have sparked skepticism among some experts, highlighting the desperation to find new treatments as the virus becomes increasingly resistant to mainline therapies.
Drugs
Foster City, Calif.--(HealthWire)--Sept. 18, 1995--Gilead Sciences, Inc. (Nasdaq: GILD) announced today the presentation of interim data from a randomized, controlled pivotal study indicating that VISTIDE(TM) (cidofovir intravenous) delayed the time to progression of retinitis in patients with relapsing CMV retinitis, when compared to historical controls. Prior
Drugs
ImmuLogic Pharmaceutical Corp., a biotechnology company, has announced a public offering of 2,400,000 shares of its common stock at a price of $10.75 per share, generating gross proceeds of $25,800,000. The company plans to utilize the proceeds for product research, development, and manufacturing, as well
Drugs
Collagen Corp., a technology-based company based in Palo Alto, has filed an amended complaint in its lawsuit against Matrix Pharmaceutical Inc. for allegedly stealing trade secrets. The amended complaint names two former Collagen employees as additional defendants, Steven W. Carlson and Daniel R. Prows, who allegedly took proprietary manufacturing process
Drugs
The professional era of rugby union was only seven days old when it encountered its first drugs scandal, with at least 150 players from both codes allegedly linked to anabolic steroid use. The allegations, which came from a radio programme, have sparked a debate about the sport's vulnerability
Drugs
Former heavyweight champion Oliver McCall has been suspended by the World Boxing Council (WBC) for refusing to undergo a mandatory anti-doping test after his defeat to Frank Bruno at Wembley Stadium last Saturday. McCall's decision has raised suspicions about the legitimacy of the fight, particularly given his history
Drugs
President Clinton has granted the FDA authority to regulate tobacco products, citing their addictive nature and the devastating health consequences for young people. The agency's proposal aims to curb youth access to tobacco, with rules ranging from prohibiting sales to minors to banning the use of certain marketing
Drugs
Texas Biotechnology Corporation has met a technical milestone in its computer-aided drug design program, triggering an additional research payment of $2 million from Eisai Co., Ltd. of Japan. The company, led by President and CEO David B. McWilliams, has successfully applied proprietary computer-aided drug design technology to develop small molecule
